寶塔實業(000595.SZ)反彈超5% 澄清未向人民法院申請破產
格隆匯12月24日丨昨日逼近跌停的寶塔實業(000595.SZ)今日出現明顯反彈,現報3.25元,漲6.21%,暫成交8516萬元,最新總市值24.84億元。

公司昨晚澄清媒體報道稱,經寶塔石化與銀川市中級人民法院核實,截至目前,銀川市兩級人民法院未收到針對寶塔石化的破產申請,寶塔石化也未向人民法院申請破產。
寶塔實業20日公告,因資金狀況緊張,出現部分債務逾期。截至2019年12月20日,公司債務逾期本金累計為4739.57萬元,相關逾期債務涉及的尚未支付的利息合計為128.67萬元,以上合計為4868.24萬元,佔公司2018年經審計淨資產的7.78%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.